Skip to main content

AMETEK Moves Up In Analyst Rankings, Passing ABIOMED

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, AMETEK Inc (AME) has taken over the #14 spot from ABIOMED, Inc. (ABMD), according to ETF Channel..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.